Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)

Clinical trial NCT00811967 · TERMINATED

Trial details

NCT number: NCT00811967
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic Liver Cirrhosis

Start date: 2003-02-01
Primary completion: 2006-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.